Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2.
Saved in:
| Title: | Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2. |
|---|---|
| Authors: | Nobori H; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: haruaki.nobori@shionogi.co.jp., Baba K; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: keiko.baba@shionogi.co.jp., Kuroda T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: takayuki.kuroda@shionogi.co.jp., Baba K; Shionogi TechnoAdvance Research & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: kaoru.baba@shionogi.co.jp., Matsumoto K; Shionogi TechnoAdvance Research & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: kazumi.matsumoto@shionogi.co.jp., Yoshida S; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: shinpei.yoshida@shionogi.co.jp., Watari R; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: ryosuke.watari@shionogi.co.jp., Tachibana Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: yuki.tachibana@shionogi.co.jp., Kato T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: teruhisa.kato@shionogi.co.jp., Fukao K; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: keita.fukao@shionogi.co.jp. |
| Source: | Antiviral research [Antiviral Res] 2024 Apr; Vol. 224, pp. 105852. Date of Electronic Publication: 2024 Feb 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38428748 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nobori+H%22">Nobori H</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: haruaki.nobori@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Baba+K%22">Baba K</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: keiko.baba@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Kuroda+T%22">Kuroda T</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: takayuki.kuroda@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Baba+K%22">Baba K</searchLink>; Shionogi TechnoAdvance Research & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: kaoru.baba@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Matsumoto+K%22">Matsumoto K</searchLink>; Shionogi TechnoAdvance Research & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: kazumi.matsumoto@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Yoshida+S%22">Yoshida S</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: shinpei.yoshida@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Watari+R%22">Watari R</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: ryosuke.watari@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Tachibana+Y%22">Tachibana Y</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: yuki.tachibana@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Kato+T%22">Kato T</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: teruhisa.kato@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Fukao+K%22">Fukao K</searchLink>; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: keita.fukao@shionogi.co.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228109699%22">Antiviral research</searchLink> [Antiviral Res] 2024 Apr; Vol. 224, pp. 105852. <i>Date of Electronic Publication: </i>2024 Feb 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8109699 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-9096 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201663542%22">01663542 </searchLink><i>NLM ISO Abbreviation: </i>Antiviral Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38428748 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.antiviral.2024.105852 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105852 Titles: – TitleFull: Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nobori H – PersonEntity: Name: NameFull: Baba K – PersonEntity: Name: NameFull: Kuroda T – PersonEntity: Name: NameFull: Baba K – PersonEntity: Name: NameFull: Matsumoto K – PersonEntity: Name: NameFull: Yoshida S – PersonEntity: Name: NameFull: Watari R – PersonEntity: Name: NameFull: Tachibana Y – PersonEntity: Name: NameFull: Kato T – PersonEntity: Name: NameFull: Fukao K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1872-9096 Numbering: – Type: volume Value: 224 Titles: – TitleFull: Antiviral research Type: main |
| ResultId | 1 |